Sep 15, 2026 09:16AM
Sep 15, 2026 09:15AM
Sep 14, 2026 08:00AM
Sep 2, 2026 08:30AM
Aug 13, 2026 04:15PM
Aug 6, 2026 12:31PM
Aug 6, 2026 08:01AM Ensysce Biosciences acquires Cy Biopharma with up to $77M financing
Aug 6, 2026 08:00AM
Jul 14, 2026 08:01AM
Jul 14, 2026 08:00AM
Jun 26, 2026 08:02AM
Jun 26, 2026 08:00AM
May 15, 2026 04:15PM
May 12, 2026 08:09AM Ensysce Biosciences receives Taiwan patent for overdose protection technology
May 12, 2026 08:00AM
Apr 16, 2026 08:04AM
Apr 16, 2026 08:00AM
Mar 30, 2026 04:50PM
Mar 3, 2026 08:02AM
Mar 3, 2026 08:00AM
Jan 5, 2026 08:03AM Ensysce secures up to $20 million in funding, advances phase 3 opioid trial
Jan 5, 2026 08:00AM
Dec 2, 2025 08:05AM
Dec 2, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 14, 2025 04:15PM
Aug 13, 2025 04:15PM Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
Jul 31, 2025 08:00AM
Jul 31, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jun 24, 2025 08:00AM
Jun 4, 2025 08:12AM
Jun 4, 2025 08:00AM Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection
May 13, 2025 04:15PM
Apr 15, 2025 08:04AM
Apr 15, 2025 08:00AM
Mar 10, 2025 04:15PM
Mar 3, 2025 09:43AM
Feb 5, 2025 08:05AM
Feb 5, 2025 08:00AM Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment
Jan 22, 2025 08:01AM
Jan 22, 2025 08:00AM
Jan 8, 2025 08:03AM
Jan 8, 2025 08:00AM
Nov 26, 2024 08:00AM
Nov 12, 2024 04:15PM
Oct 2, 2024 08:08AM Ensysce Biosciences (ENSC) Provides Shareholder Update, Responds to Recent Shareholder Inquiries
Oct 2, 2024 08:00AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All